United States

Hyperscale Data Provides Business Update; Reports $25 Million in Q1 Revenue and Reaffirms $115–$125 Million Full-Year Revenue Guidance

LAS VEGAS, May 21, 2025 (GLOBE NEWSWIRE) — Hyperscale Data, Inc. (NYSE American: GPUS), a diversified holding company (“Hyperscale Data” or the “Company”), yesterday filed its Form 10-Q for the quarter ended March 31, 2025. The…

Read More »

Radware Recognized as a Leader and Fast Mover in the GigaOm Radar for Application and API Security

Curium and NRG PALLAS extend collaboration in the supply of essential medical isotope to hospitals

EuroPCR 2025: Late-Breaking Data Demonstrate Sustained Significantly Lower Event Rates With Elixir Medical’s DynamX Bioadaptor Over Drug-Eluting Stent Through Three Years

Who really calls the shots at sea? New research sheds light on hidden ownership of the world’s industrial fishing fleets

Belite Bio Announces FDA Granting of Breakthrough Therapy Designation for Tinlarebant for the Treatment of Stargardt Disease

Turntide Gen 5 Battery Provides OEMs Faster Time-to-Market with Built-in Compliance

Sterling Trading Tech and eflow Global launch webinar series on risk management in volatile markets

CRB opens office near Munich, Germany to serve growing life sciences demand

WEBRIS Launches Fully Managed Facebook Ads Program Built Exclusively for Law Firms

Cipher Mining Prices Convertible Senior Notes Offering and Hedging Transaction to Place Borrowed Common Stock

Texas Veterans Tell Lawmakers to Vote No on CSSB 3 to Protect Their Right to Heal

AMD Introduces New Radeon Graphics Cards and Ryzen Threadripper Processors at COMPUTEX 2025

LAS VEGAS SPHERE NAMED YEAR’S MOST OUTSTANDING ENGINEERING ACHIEVEMENT

FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC Continues Lead Plaintiff Search for Viatris Inc. (VTRS) Securities Fraud Class Action

Liferay Launches Liferay DXP Availability in AWS Marketplace

HeyShape Under Review: Best Seamless Shaping Bodysuit Shapewear for Snatched Fit & Hourglass Enhancement

ATNM INVESTOR ALERT: Kirby McInerney LLP Reminds Actinium Pharmaceuticals, Inc. Investors of Looming Lead Plaintiff Deadline in Class Action Lawsuit